CIBC World Markets’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$163K Sell
14,461
-11,155
-44% -$102K ﹤0.01% 1320
2025
Q1
$243K Buy
25,616
+14,813
+137% +$150K ﹤0.01% 1362
2024
Q4
$122K Buy
+10,803
New +$190K ﹤0.01% 1193

Other funds holding EVH

CIBC World Markets's EVH Position: Q2 2025 in Review

CIBC World Markets reduced its Evolent Health (EVH) stake by 44% in Q2 2025, selling an estimated $102K and leaving 14,461 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #1320.

CIBC World Markets first reported a position in EVH in Q4 2024 and has held it in 3 quarters since. The position peaked at $243K in Q1 2025. 220 funds tracked by Wall St. Rank hold EVH as of Q2 2025.

  • CIBC World Markets held 14,461 shares of Evolent Health worth $163K as of Q2 2025.
  • CIBC World Markets sold 11,155 Evolent Health shares in Q2 2025, an estimated $102K.
  • Evolent Health made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1320 holding.
  • CIBC World Markets first reported a position in Evolent Health in Q4 2024 and has held it in 3 quarters since.
  • CIBC World Markets's Evolent Health position peaked at $243K in Q1 2025.
  • 220 funds tracked by Wall St. Rank held Evolent Health as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.